Vermillion (VRML) Names Industry Vet Thomas McLain as CEO

March 13, 2013 8:32 AM EDT Send to a Friend
Vermillion, Inc. (NASDAQ: VRML) has appointed Thomas McLain as president and chief executive officer effective March 18, 2013. He succeeds Bruce Huebner, the company's interim chief executive officer, who will remain a director of the company and assist in the transition.

McLain brings to Vermillion more than 20 years of experience in executive management and corporate governance for both public and privately held companies, with a strong record of turning companies into leading players in the medical diagnostic and biotechnology industry.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Management Changes

Add Your Comment